Nordic Pharma Lab ApS: Financial statements 2020
CVR: 39161672
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
Nordic Pharma Lab ApS (CVR 39161672) has filed annual accounts for 2020. In 2020, the company reported revenue of DKK 1 and a net result of DKK -20,276 compared with DKK -11,668 the year before. The profit margin was -2,027,600%. Equity in the 2020 report amounted to DKK 56,716. The solvency ratio was 26.8%.
- Revenue
- DKK 1
- Gross Profit
- DKK -40,667
- Profit/Loss
- DKK -20,276
- Equity
- DKK 56,716
- Total Assets
- DKK 211,627
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | 1 | -41 t. | -20 t. | 57 t. | - |
| 2019 | - | -12 t. | -12 t. | 77 t. | - |
| 2018 | - | -11 t. | -11 t. | 89 t. | - |
Official annual report
How creditworthy is Nordic Pharma Lab ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
As of October 1, 2020, Beier Holding ApS is registered as an owner of Nordic Pharma Lab ApS with an ownership share of 20%.
Nordic Pharma Lab ApS has published its annual report for 2019. Gross profit came to DKK -11,588, and the net result was DKK -11,668.
As of June 24, 2020, TT 1919 ApS is registered as an owner of Nordic Pharma Lab ApS with an ownership share of 5%.
As of January 15, 2020, VULKAN INVEST ApS is registered as an owner of Nordic Pharma Lab ApS with an ownership share of 5%.
About Nordic Pharma Lab ApS
Nordic Pharma Lab ApS is a Danish company of the type Anpartsselskab based in Hørsholm, founded in 2017. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named ApS STM nr. 6145. The management consists of Torsten Bjørn. The company's owners include TT 1919 ApS, Beier Holding ApS and FINANSMANAGEMENT ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -52,093 and a net result of DKK -110,916 compared with DKK -30,573 the year before. Equity in the 2025 report amounted to DKK -429,426.